IN-B00009 Injection

IN-B00009 · HK inno.N Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IN-B00009 Injection, covering 2025-09-25 to 2025-09-25. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Adults With Obesity or Overweight Without Diabetes Mellitus [Phase 3]

See pricing